Paper41359628
The deubiquitinating enzyme Cezanne stabilizes BRCA1 by counteracting APC/C and Ube2S-dependent Lys11-linked ubiquitination.
Wang L and 4 others. PLoS Biol, 2025. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The deubiquitinating enzyme Cezanne stabilizes BRCA1 by counteracting APC/C and Ube2S-dependent Lys11-linked ubiquitination. Papers, record 41359628. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41359628
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The deubiquitinating enzyme Cezanne stabilizes BRCA1 by counteracting APC/C and Ube2S-dependent Lys11-linked ubiquitination.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ubiquitin-Conjugating Enzymes | Major topic |
| BRCA1 Protein | Major topic |
| Deubiquitinating Enzymes | Major topic |
| Anaphase-Promoting Complex-Cyclosome | Major topic |
| Ubiquitination | |
| Humans | |
| Female | |
| Breast Neoplasms | |
| Lysine | |
| Protein Stability | |
| Cell Line, Tumor | |
| HEK293 Cells | |
| Cadherins |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 CA248088 | NCI NIH HHS | United States | R01CA248088 | PubMed |
Source NIH RePORTER
References67
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17525340 | Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response. | Science | 2007 | https://conductscience.org/library/papers/17525340 | PubMed |
| 2 | 15829966 | Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. | Nature | 2005 | https://conductscience.org/library/papers/15829966 | PubMed |
| 3 | 19261749 | NBA1, a new player in the Brca1 A complex, is required for DNA damage resistance and checkpoint control. | Genes Dev | 2009 | https://conductscience.org/library/papers/19261749 | PubMed |
| 4 | 27732584 | Molecular basis of Lys11-polyubiquitin specificity in the deubiquitinase Cezanne. | Nature | 2016 | https://conductscience.org/library/papers/27732584 | PubMed |
| 5 | 34527184 | Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer. | Comput Struct Biotechnol J | 2021 | https://conductscience.org/library/papers/34527184 | PubMed |
| 6 | 37578980 | DNA repair function scores for 2172 variants in the BRCA1 amino-terminus. | PLoS Genet | 2023 | https://conductscience.org/library/papers/37578980 | PubMed |
| 7 | 11278247 | The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11278247 | PubMed |
| 8 | 30760478 | PARP Inhibitors: Extending Benefit Beyond BRCA-Mutant Cancers. | Clin Cancer Res | 2019 | https://conductscience.org/library/papers/30760478 | PubMed |
| 9 | 24002223 | Push back to respond better: regulatory inhibition of the DNA double-strand break response. | Nat Rev Mol Cell Biol | 2013 | https://conductscience.org/library/papers/24002223 | PubMed |
| 10 | 19820702 | UBE2S elongates ubiquitin chains on APC/C substrates to promote mitotic exit. | Nat Cell Biol | 2009 | https://conductscience.org/library/papers/19820702 | PubMed |
| 11 | 22460905 | The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. | Nature | 2012 | https://conductscience.org/library/papers/22460905 | PubMed |
| 12 | 28302823 | PARP inhibitors: Synthetic lethality in the clinic. | Science | 2017 | https://conductscience.org/library/papers/28302823 | PubMed |
| 13 | 24472556 | HUWE1 interacts with BRCA1 and promotes its degradation in the ubiquitin-proteasome pathway. | Biochem Biophys Res Commun | 2014 | https://conductscience.org/library/papers/24472556 | PubMed |
| 14 | 15166217 | Ubiquitination and proteasomal degradation of the BRCA1 tumor suppressor is regulated during cell cycle progression. | J Biol Chem | 2004 | https://conductscience.org/library/papers/15166217 | PubMed |
| 15 | 8576261 | Novel multiubiquitin chain linkages catalyzed by the conjugating enzymes E2EPF and RAD6 are recognized by 26 S proteasome subunit 5. | J Biol Chem | 1996 | https://conductscience.org/library/papers/8576261 | PubMed |
| 16 | 23086937 | The F-box protein FBXO44 mediates BRCA1 ubiquitination and degradation. | J Biol Chem | 2012 | https://conductscience.org/library/papers/23086937 | PubMed |
| 17 | 24142877 | Physiological modulation of endogenous BRCA1 p220 abundance suppresses DNA damage during the cell cycle. | Genes Dev | 2013 | https://conductscience.org/library/papers/24142877 | PubMed |
| 18 | 26778126 | Structure of BRCA1-BRCT/Abraxas Complex Reveals Phosphorylation-Dependent BRCT Dimerization at DNA Damage Sites. | Mol Cell | 2016 | https://conductscience.org/library/papers/26778126 | PubMed |
| 19 | 1846030 | Cyclin is degraded by the ubiquitin pathway. | Nature | 1991 | https://conductscience.org/library/papers/1846030 | PubMed |
| 20 | 8780884 | BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. | Cell Growth Differ | 1996 | https://conductscience.org/library/papers/8780884 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42942146 | Beyond Homologous Recombination: Functional Modules of Olaparib Resistance Revealed by CRISPR Screens. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42942146 |
Source PubMed
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BRCA1 | 672 | PubTator's text mining | https://conductscience.org/library/genes/672 | NCBI Gene |
| CDH1 | 999 | PubTator's text mining | https://conductscience.org/library/genes/999 | NCBI Gene |
| OTUD7B | 56957 | PubTator's text mining | https://conductscience.org/library/genes/56957 | NCBI Gene |
| UBE2S | 27338 | PubTator's text mining | https://conductscience.org/library/genes/27338 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41359628
GET https://conductscience.org/api/papers/v1/41359628/references?page=2